Top Markets
#1 Akedo Akedo +81.28%
#2 TENDIES TENDIES +81.05%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +43.65%
#5 MultiversX MultiversX +34.16%
#6 Mubarak Mubarak +31.57%
#7 Cash Cat Cash Cat +25.19%
#8 Bitway Bitway +18.39%
#9 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#10 OSK OSK +16.18%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Neovasc Inc. Neovasc Inc.

Neovasc Inc.

NVCN
Rank in Stocks #17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Share Price
$29.82
Last synced: 2023-04-11
Market Cap
$223.68M
Change (1 day)
1.21%
Change (1 year)
0.00%
Country
CA
Trade Neovasc Inc. (NVCN)

Category

Healthcare
Revenue for Neovasc Inc. (NVCN)
Revenue in Sep 2026 TTM: 0
According to Neovasc Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Neovasc Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US